Healthcare provider profile · identity verified

Jennifer A. Wheeler, MD

Family Practice · MOUNTAIN TOP, PA · NPI 1972706182

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	788	223
Lisinopril	Lisinopril	471	133
Levothyroxine Sodium	Levothyroxine Sodium	463	115
Amlodipine Besylate	Amlodipine Besylate	378	100
Gabapentin	Gabapentin	280	62
Omeprazole	Omeprazole	278	87
Metoprolol Succinate	Metoprolol Succinate	273	71
Losartan Potassium	Losartan Potassium	247	71
Metformin Hcl Er	Metformin Hcl	244	66
Rosuvastatin Calcium	Rosuvastatin Calcium	216	57
Hydrochlorothiazide	Hydrochlorothiazide	197	64
Eliquis	Apixaban	173	35
Duloxetine Hcl	Duloxetine Hcl	163	36
Metformin Hcl	Metformin Hcl	161	47
Carvedilol	Carvedilol	142	40
Famotidine	Famotidine	141	46
Baclofen	Baclofen	137	43
Albuterol Sulfate Hfa	Albuterol Sulfate	130	44
Furosemide	Furosemide	128	36
Pantoprazole Sodium	Pantoprazole Sodium	121	38
Sertraline Hcl	Sertraline Hcl	120	34
Ozempic	Semaglutide	118	24
Simvastatin	Simvastatin	117	34
Jardiance	Empagliflozin	113	24
Trazodone Hcl	Trazodone Hcl	109	27
Metoprolol Tartrate	Metoprolol Tartrate	95	24
Venlafaxine Hcl Er	Venlafaxine Hcl	90	14
Tramadol Hcl	Tramadol Hcl	87	21
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	86	16
Warfarin Sodium	Warfarin Sodium	86	21
Alprazolam	Alprazolam	84	25
Clopidogrel	Clopidogrel Bisulfate	83	22
Tamsulosin Hcl	Tamsulosin Hcl	80	25
Allopurinol	Allopurinol	76	26
Atenolol	Atenolol	76	16
Potassium Chloride	Potassium Chloride	72	21
Clonazepam	Clonazepam	70	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	70	20
Fluticasone Propionate	Fluticasone Propionate	67	31
Buspirone Hcl	Buspirone Hcl	65	19
Ezetimibe	Ezetimibe	64	20
Ipratropium Bromide	Ipratropium Bromide	63	37
Pregabalin	Pregabalin	63	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	60	17
Torsemide	Torsemide	60	21
Glipizide Er	Glipizide	59	16
Oxycodone Hcl	Oxycodone Hcl	59	12
Bupropion Xl	Bupropion Hcl	55	15
Montelukast Sodium	Montelukast Sodium	52	14
Prednisone	Prednisone	52	35
Clonidine Hcl	Clonidine Hcl	49	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	49	16
Escitalopram Oxalate	Escitalopram Oxalate	47	14
Zolpidem Tartrate	Zolpidem Tartrate	47	suppressed
Pravastatin Sodium	Pravastatin Sodium	46	13
Valsartan	Valsartan	46	suppressed
Novolog Flexpen	Insulin Aspart	45	12
Paroxetine Hcl	Paroxetine Hcl	45	15
Meloxicam	Meloxicam	44	15
Diclofenac Sodium	Diclofenac Sodium	40	14
Hydralazine Hcl	Hydralazine Hcl	40	12
Januvia	Sitagliptin Phosphate	38	suppressed
Lorazepam	Lorazepam	37	14
Mirtazapine	Mirtazapine	37	12
Tizanidine Hcl	Tizanidine Hcl	37	suppressed
Topiramate	Topiramate	36	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	35	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	suppressed
Olanzapine	Olanzapine	33	suppressed
Ondansetron Hcl	Ondansetron Hcl	33	25
Ventolin Hfa	Albuterol Sulfate	33	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	32	suppressed
Repaglinide	Repaglinide	32	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	31	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	30	14
Donepezil Hcl	Donepezil Hcl	29	suppressed
Synthroid	Levothyroxine Sodium	29	suppressed
Tradjenta	Linagliptin	28	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	27	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	27	suppressed
Valacyclovir	Valacyclovir Hcl	27	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	26	23
Doxazosin Mesylate	Doxazosin Mesylate	26	suppressed
Spironolactone	Spironolactone	26	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	26	suppressed
Benazepril Hcl	Benazepril Hcl	25	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	25	14
Glimepiride	Glimepiride	24	suppressed
Ondansetron Odt	Ondansetron	23	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	23	suppressed
Citalopram Hbr	Citalopram Hydrobromide	22	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	22	19
Lansoprazole	Lansoprazole	22	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	22	16
Sumatriptan Succinate	Sumatriptan Succinate	22	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	22	suppressed
Alendronate Sodium	Alendronate Sodium	21	suppressed
Trulicity	Dulaglutide	21	suppressed
Chlorthalidone	Chlorthalidone	20	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	20	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	19	suppressed
Jantoven	Warfarin Sodium	19	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Ibuprofen	Ibuprofen	18	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Liothyronine Sodium	Liothyronine Sodium	18	suppressed
Modafinil	Modafinil	18	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Nitroglycerin	Nitroglycerin	17	14
Olmesartan Medoxomil	Olmesartan Medoxomil	17	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Cefuroxime	Cefuroxime Axetil	16	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Fosinopril Sodium	Fosinopril Sodium	16	suppressed
Nadolol	Nadolol	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	14
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	15	suppressed
Fenofibric Acid	Fenofibric Acid (Choline)	15	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	14	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	14	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Mupirocin	Mupirocin	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Ranolazine Er	Ranolazine	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Celecoxib	Celecoxib	13	suppressed
Cimetidine	Cimetidine	13	suppressed
Diazepam	Diazepam	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	12	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Methocarbamol	Methocarbamol	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Spiriva Handihaler	Tiotropium Bromide	12	suppressed
Temazepam	Temazepam	12	suppressed
Testosterone Cypionate	Testosterone Cypionate	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Xtampza Er	Oxycodone Myristate	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Azithromycin	Azithromycin	11	suppressed
Colesevelam Hcl	Colesevelam Hcl	11	suppressed
Digoxin	Digoxin	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error